Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Laeken, Belgium Clinical Trials

A listing of Laeken, Belgium clinical trials actively recruiting patients volunteers.

RESULTS

Found (7) clinical trials

An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease

Participants who meet other study entry requirements will be required to undergo either an amyloid positron emission tomography (PET) scan or a lumbar puncture for cerebrospinal fluid (CSF) sampling at screening to document presence of abnormal levels of brain and CSF amyloid for study inclusion. The study includes 2 sub-studies: ...

Phase

0.51 miles

Learn More »

Iclusig (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium

This prospective registry is initiated to follow up on the use of Iclusig in patients with CML or Ph+ ALL in routine practice in Belgium.

Phase N/A

1.02 miles

Learn More »

Single-center Prospective Cumulus Cell Test Study in rFSH Patients

Performing an additional non-invasive oocyte diagnostic test based on cumulus cell gene expression could improve the outcome of the ART cycle for rFSH stimulated patients

Phase N/A

1.41 miles

Learn More »

Fixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World Setting

This non-interventional study assesses the real-life effectiveness and safety of the fixed triple therapy Trimbow compared to free triple therapy, considering patient individual data, in clinical practice at second and thirdline centres in patients with confirmed moderate to severe chronic obstructive pulmonary disease. This is an hypothesis generating study. No ...

Phase N/A

1.86 miles

Learn More »

Pilot Study to Evaluate the Safety and the Efficacy of the Modified Matrix Obtained by the AmeaCell Device and Intended for the Filling of Wrinkles on the Face.

The purpose of this study is to evaluate the filling using the modified matrix, obtained by the Ameacell device from autologous adipose tissue and intended for the filling of wrinkles on the face. This is a mono-center, pilot study in 24 subjects

Phase N/A

1.86 miles

Learn More »

Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial)

Open-label, interventional, multi-centre, randomized phase II study. Cancer studied is non-metastatic muscle invasive bladder cancer (MIBC) Patients (male or female) will receive avelumab every 2 weeks in combination with standard chemotherapy or alone. There are 2 cohorts of patients. Cohort with patients cisplatin-ineligible will receive either avelumab alone or in ...

Phase

2.38 miles

Learn More »

Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics

This study is designed to assess the effect of PF-06865571 administration on the pharmacokinetics of metformin in healthy adult subjects.

Phase

4.42 miles

Learn More »